Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation

Life Sciences

Volumn 84, Issue 9-10, 2009, Pages 257-262

  Sul, Donggeun ^a   Kim, Hyo Shin ^b   Lee, Dongho ^c   Joo, Seong Soo ^d   Hwang, Kwang Woo ^b   Park, So Young ^a  

^a Korea University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c Korea University   (South Korea)

^d Chungbuk National University   (South Korea)

Author keywords

Antioxidant; Beta amyloid; Caffeic acid; Calcium influx; GSK 3 ; Tau phosphorylation

Indexed keywords

AMYLOID BETA PROTEIN; CAFFEIC ACID; CALCIUM; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; CAFFEIC ACIDS; CALCIUM; PC12 CELLS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; TAU PROTEINS;

EID: 59649111139     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.12.001     Document Type: Article

References (53)

1. Ben J.Y., Cho S.O., Koh S.B., Song K.S., Bae K., and Seong Y.H. Protection of amyloid beta protein (25-35)-induced neurotoxicity by methanol extract of Smilacis chinae rhizome in cultured rat cortical neurons. Journal of Ethnopharmacology 106 (2006) 230-237
2. Bensadoun A., and Weinstein D. Assay of proteins in the presence of interfering materials. Analytical Biochemistry 70 (1976) 241-250
3. Berridge M.J., Lipp P., and Bootman M.D. Signal transduction. The calcium entry pas de deux. Science 287 (2000) 1604-1605
4. Busciglio J., Lorenzo A., Yeh J., and Yankner B.A. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14 (1995) 879-888
5. Chen G., Bower K.A., Ma C., Fang S., Thiele C.J., and Luo J. Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB Journal 18 (2004) 1162-1164
6. Chung T.W., Moon S.K., Chang Y.C., Ko J.H., Lee Y.C., Cho G., Kim S.H., Kim J.G., and Kim C.H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB Journal 18 (2004) 1670-1681
7. Cummings J.L., Vinters H.V., Cole G.M., and Khachaturian Z.S. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51 (1998) S2-S17
8. Devipriya N., Sudheer A.R., and Menon V.P. Caffeic acid protects human peripheral blood lymphocytes against gamma radiation-induced cellular damage. Journal of Biochemical and Molecular Toxicology 22 (2008) 175-186
9. Ferreira A., Busciglio J., and Caceres A. Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau. Brain Research Developmental Brain Research 49 (1989) 215-228
10. Friedman M. Chemistry, biochemistry, and dietary role of potato polyphenols. A review. Journal of Agricultural and Food Chemistry 45 (1997) 1523-1540
11. Fu H., Li W., Lao Y., Luo J., Lee N.T., Kan K.K., Tsang H.W., Tsim K.W., Pang Y., Li Z., Chang D.C., Li M., and Han Y. Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels. Journal of Neurochemistry 98 (2006) 1400-1410
12. Gauthier S., Emre M., Farlow M.R., Bullock R., Grossberg G.T., and Potkin S.G. Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors. Current Medical Research and Opinion 19 (2003) 707-714
13. Greenberg S.M., Qiu W.Q.., Selkoe D.J., Ben-Itzhak A., and Kosik K.S. Amino-terminal region of the beta-amyloid precursor protein activates mitogen-activated protein kinase. Neuroscience Letters 198 (1995) 52-56
14. Griffin R.J., Moloney A., Kelliher M., Johnston J.A., Ravid R., Dockery P., O'Connor R., and O'Neill C. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. Journal of Neurochemistry 93 (2005) 105-117
15. Haass C., and Selkoe D.J. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75 (1993) 1039-1042
16. Henderson V.W. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 48 (1997) S27-S35
17. Hu M., Waring J.F., Gopalakrishnan M., and Li J. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells. Journal of Neurochemistry 31 (2008) 1371-1377
18. Hudson B.J.F., and Mahgoub S.E. Naturally occurring antioxidants in leaf lipids. Journal of the Science of Food and Agriculture 31 (1980) 646-650
19. Kawahara M., and Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Research Bulletin 53 (2000) 389-397
20. Kelly B.L., and Ferreira A. beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. Journal of Biological Chemistry 281 (2006) 28079-28089
21. Klein W.L., Kraft G.A., and Finch C.E. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?. Trends in Neurosciences 24 (2001) 219-224
22. Kondo J., Honda T., Mori H., Hamada Y., Miura R., Ogawara M., and Ihara Y. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1 (1988) 827-834
23. Konishi Y., Hitomi Y., Yoshida M., and Yoshioka E. Pharmacokinetic study of caffeic and rosmarinic acids in rats after oral administration. Journal of Agricultural and Food Chemistry 53 (2005) 4740-4746
24. Koo K.A., Kim S.H., Oh T.H., and Kim Y.C. Acteoside and its aglycones protect primary cultures of rat cortical cells from glutamate-induced excitotoxicity. Life Sciences 79 (2006) 709-716
25. Koshihara Y., Neichi T., Murota S., Lao A., Fujimoto Y., and Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochimica et Biophysica Acta 792 (1984) 92-97
26. Kosik K.S., Joachim C.L., and Selkoe D.J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 83 (1986) 4044-4048
27. Ky C.L., Noirot M., and Hamon S. Comparison of five purification methods for chlorogenic acids in green coffee beans (Coffea sp.). Journal of Agricultural and Food Chemistry 45 (1997) 786-790
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
29. Leschik J., Welzel A., Weissmann C., Eckert A., and Brandt R. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death. Journal of Neurochemistry 101 (2007) 1303-1315
30. Lodovici M., Guglielmi F., Meoni M., and Dolara P. Effect of natural phenolic acids on DNA oxidation in vitro. Food and Chemical Toxicology 39 (2001) 1205-1210
31. Lovell M.A., Xiong S., Xie C., Davies P., and Markesbery W.R. Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. Journal of Alzheimer's Disease 6 (2004) 659-671
32. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
33. Muller W.E., Romero F.J., Perovic S., Pergande G., and Pialoglou P. Protection of flupirtine on beta-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion. Journal of Neurochemistry 68 (1997) 2371-2377
34. Park S.Y., and Kim D.S. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. Journal of Natural Products 65 (2002) 1227-1231
35. Park S.Y., Kim H.S., Cho E.K., Kwon B.Y., Phark S., Hwang K.W., and Sul D. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food and Chemical Toxicology 46 (2008) 2881-2887
36. Pasinetti G.M., and Aisen P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87 (1998) 319-324
37. Phiel C.J., Wilson C.A., Lee V.M., and Klein P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423 (2003) 435-439
38. Pike C.J., Walencewicz A.J., Glabe C.G., and Cotman C.W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Research 563 (1991) 311-314
39. Rank K.B., Pauley A.M., Bhattacharya K., Wang Z., Evans D.B., Fleck T.J., Johnston J.A., and Sharma S.K. Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II. FEBS Letters 514 (2002) 263-268
40. Rapoport M., and Ferreira A. PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons. Journal of Neurochemistry 74 (2000) 125-133
41. Rapoport M., Dawson H.N., Binder L.I., Vitek M.P., and Ferreira A. Tau is essential to beta-amyloid-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 6364-6369
42. Rice-Evans C.A., Miller N.J., and Paganga G. Antioxidant properties of phenolic compounds. Trends in Plant Science 2 (1997) 152-159
43. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275 (1997) 630-631
44. Selenica M.L., Jensen H.S., Larsen A.K., Pedersen M.L., Helboe L., Leist M., and Lotharius J. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation. British Journal of Pharmacology 152 (2007) 959-979
45. Simakova O., and Arispe N.J. Early and late cytotoxic effects of external application of the Alzheimer's Abeta result from the initial formation and function of Abeta ion channels. Biochemistry 45 (2006) 5907-5915
46. Smith R.C., Reeves J.C., Dage R.C., and Schnettler R.A. Antioxidant properties of 2-imidazolones and 2-imidazolthiones. Biochemical Pharmacology 36 (1987) 1457-1460
47. Takashima A., Honda T., Yasutake K., Michel G., Murayama O., Murayama M., Ishiguro K., and Yamaguchi H. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neuroscience Research 31 (1998) 317-323
48. Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., and Mori H. Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 14 (1993) 1321-1325
49. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America 76 (1979) 4350-4354
50. Winstein C.J., Bentzen K.R., Boyd L., and Schneider L.S. Does the cholinesterase inhibitor, donepezil, benefit both declarative and non-declarative processes in mild to moderate Alzheimer's disease?. Current Alzheimer Research 4 (2007) 273-276
51. Wood J.G., Mirra S.S., Pollock N.J., and Binder L.I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proceedings of the National Academy of Sciences of the United States of America 83 (1986) 4040-4043
52. Zheng W.H., Bastianetto S., Mennicken F., Ma W., and Kar S. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115 (2002) 201-211
53. Zhou X.W., Li X., Bjorkdahl C., Sjogren M.J., Alafuzoff I., Soininen H., Grundke-Iqbal I., Iqbal K., Winblad B., and Pei J.J. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains. Neurobiology of Disease 22 (2006) 657-668